EstroPRO Homeopathic Organotherapy
NDC 43853-0038, Agnus Castus, Angelica Sin, Apis Mel, Cimicifuga Rac, Estradiol, Estriol, Folliculinum, Galium, Glycyrrhiza, Oophorinum, Progesterone, Sepia, spray, from ProBlen.
- Product NDC
- 43853-0038
- Status
- Listed
- Labeler
- ProBlen
- Dosage form
- SPRAY
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43853-0038 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHASTE TREE3 [hp_X]/mL
- ANGELICA SINENSIS ROOT3 [hp_X]/mL
- APIS MELLIFERA6 [hp_X]/mL
- BLACK COHOSH3 [hp_X]/mL
- ESTRADIOL9 [hp_C]/mL
- ESTRIOL9 [hp_C]/mL
- ESTRONE9 [hp_C]/mL
- GALIUM APARINE3 [hp_X]/mL
- GLYCYRRHIZA GLABRA3 [hp_X]/mL
- SUS SCROFA OVARY30 [hp_C]/mL
- PROGESTERONE6 [hp_X]/mL
- SEPIA OFFICINALIS JUICE30 [hp_C]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Estradiol Congeners [CS]; Estrogen Receptor Agonists [MoA]; Estrogen [EPC]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Progesterone [CS]; Progesterone [EPC]; Standardized Insect Venom Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43853-0038-1 | 43853003801 | 30 mL in 1 BOTTLE, SPRAY (43853-0038-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43853-0038 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43853-0038 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43853-0038. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.